We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
(+18%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$163M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$137M |
| 3 |
Repligen
RGEN
|
+$104M |
| 4 |
Biogen
BIIB
|
+$104M |
| 5 |
Zoetis
ZTS
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 2 |
Agilent Technologies
A
|
+$137M |
| 3 |
Fidelity National Information Services
FIS
|
+$86.2M |
| 4 |
Adobe
ADBE
|
+$76.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.24% |
| 2 | Consumer Discretionary | 12.89% |
| 3 | Financials | 10.77% |
| 4 | Technology | 9.62% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Vitamin Cottage Natural Grocers
NGVC
$735M
| $499K | ﹤0.01% |
+36,346
| New | +$452K |
|
1452
Pembina Pipeline
PBA
$29.2B
| $496K | ﹤0.01% |
21,000
-54,200
| -72% | -$1.27M |
|
1453
Voya Financial
VOYA
$9B
| $496K | ﹤0.01% |
8,435
-77,797
| -90% | -$4.22M |
|
1454
Impinj
PI
$3.99B
| $495K | ﹤0.01% |
+11,827
| New | +$412K |
|
|
BECN
1455
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $493K | ﹤0.01% |
12,264
-15,006
| -55% | -$548K |
|
1456
CBRE Group
CBRE
$42.9B
| $490K | ﹤0.01% |
+7,805
| New | +$441K |
|
1457
DHT Holdings
DHT
$2.96B
| $488K | ﹤0.01% |
93,140
+62,287
| +202% | +$325K |
|
1458
Kratos Defense & Security Solutions
KTOS
$9.05B
| $488K | ﹤0.01% |
+17,804
| New | +$390K |
|
1459
TE Connectivity
TEL
$59.3B
| $488K | ﹤0.01% |
4,030
-91,947
| -96% | -$10.1M |
|
1460
J.M. Smucker
SJM
$13.2B
| $487K | ﹤0.01% |
+4,213
| New | +$490K |
|
|
INFN
1461
DELISTED
Infinera Corporation Common Stock
INFN
| $487K | ﹤0.01% |
+46,486
| New | +$369K |
|
1462
Orthofix Medical
OFIX
$491M
| $484K | ﹤0.01% |
11,252
-40,012
| -78% | -$1.46M |
|
|
PRTY
1463
DELISTED
Party City Holdco Inc.
PRTY
| $483K | ﹤0.01% |
+78,578
| New | +$305K |
|
1464
Acadia Healthcare
ACHC
$2.98B
| $480K | ﹤0.01% |
+9,546
| New | +$380K |
|
1465
Hovnanian Enterprises
HOV
$803M
| $480K | ﹤0.01% |
+14,620
| New | +$528K |
|
1466
Marcus Corp
MCS
$757M
| $479K | ﹤0.01% |
+35,505
| New | +$359K |
|
|
HEP
1467
DELISTED
Holly Energy Partners, L.P.
HEP
| $478K | ﹤0.01% |
+33,654
| New | +$437K |
|
|
BDSI
1468
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $477K | ﹤0.01% |
113,584
-355,597
| -76% | -$1.37M |
|
1469
Constellium
CSTM
$3.97B
| $475K | ﹤0.01% |
+33,979
| New | +$384K |
|
1470
Liberty Media Series C
FWONK
$24.7B
| $475K | ﹤0.01% |
+11,533
| New | +$446K |
|
|
CPRX
1471
DELISTED
Catalyst Pharmaceutical
CPRX
| $474K | ﹤0.01% |
141,798
-155,182
| -52% | -$521K |
|
1472
Cue Biopharma
CUE
$137M
| $473K | ﹤0.01% |
+1,262
| New | +$504K |
|
|
TEN
1473
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $472K | ﹤0.01% |
+44,526
| New | +$421K |
|
1474
Rocket Companies
RKT
$38B
| $469K | ﹤0.01% |
23,198
-658,331
| -97% | -$13.9M |
|
|
ARNA
1475
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $469K | ﹤0.01% |
6,102
-797
| -12% | -$59.7K |
|
Similar funds
Marshall Wace's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
- Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
- Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
- Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
- Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
- Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.